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Abstract
B7-H3, a recently identified B7 family member, has different isoforms in human and mouse. Mouse B7-H3 gene has only one
isoform (2IgB7-H3) with two Ig-like domains, whereas human B7-H3 has two isoforms (2IgB7-H3 and 4IgB7-H3). In this study
a systematic genomic survey across various species from teleost fishes to mammals revealed that 4IgB7-H3 isoform also
appeared in pigs, guinea pigs, cows, dogs, African elephants, pandas, megabats and higher primate animals, which resulted
from tandem exon duplication. Further sequence analysis indicated that this duplication generated a new conserved region
in the first IgC domain, which might disable 4IgB7-H3 from releasing soluble form, while 2IgB7-H3 presented both
membrane and soluble forms. Through three-dimensional (3D) structure modeling and fusion-protein binding assays, we
discovered that the duplicated isoform had a different structure and might bind to another potential receptor on activated
T cells. In T cell proliferation assay, human 2IgB7-H3 (h2IgB7-H3) and mouse B7-H3 (mB7-H3) both increased T cell
proliferation and IL-2, IFN-c production, whereas human 4IgB7-H3 (h4IgB7-H3) reduced cytokine production and T cell
proliferation compared to control. Furthermore, both h2IgB7-H3 and mB7-H3 upregulated the function of lipopolysacharide
(LPS)-activated monocyte in vitro. Taken together, our data implied that during the evolution of vertebrates, B7-H3 exon
duplication contributed to the generation of a new 4IgB7-H3 isoform in many mammalian species, which have carried out
distinct functions in the immune responses.
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Introduction
For fine-tuning immue response, several costimulatory mole-
cules are needed including the well-known CD28 and B7 family as
B7.1 B7.2 [1]. More recently, new members of B7 family have
been discovered, such as B7-H3, which was cloned from a
dendritic cell (DC) cDNA library [2]. Genomic analysis revealed
that human B7-H3 had two isoforms, whereas mouse B7-H3 only
had one isoform. Due to exon duplication, human B7-H3 gene
contains four Ig-like domains, two pairs of IgV-IgC, which can be
alternatively spliced into two proteins: 4IgB7-H3 (B7-H3b)
containing four Ig-like domains or 2IgB7-H3 (B7-H3) with two
Ig-like domains. Mouse B7-H3 gene only expresses one protein
with two Ig-like domains [3].
Several studies demonstrated B7-H3 as a positive costimulatory
molecule and an IFN-c-inducer in activated human T cells [2,4–8].
However, other experiments showed that B7-H3 transfectants
could down-regulate T-cell proliferation and IFN-cproduction,
suggesting that it also has inhibitory effect [9–11]. Although there
were a few literatures reporting on an inhibitory role of murine
B7-H3 (mB7-H3) [10,11], a great quantity of literatures stated
that mB7-H3 acted as a positive costimulatory molecule for T cell
[5–8,12–16]. For these discrepant findings, there were two
possible explanations: one is whether there are two functionally
distinct B7-H3 receptors on T cells, as B7.1, B7.2 could bind to
T-cell receptors CD28 or CTLA-4, and thus play different
functions; the other is that two isoforms of B7-H3 might express
in human exerting different effects: one generating positive
costimulatory signal as mB7-H3, while the other acting as an
inhibitory molecule in immune responses [17–18].
Soluble costimulatory molecules, such as sCD28 or sPD-L1,
have an important role in the costimulatory regulatory network
[19]. Previously, we reported the existence of a new soluble B7-H3
(sB7-H3), which could be released from dendritic cells, monocytes
and other tumor cells by matrix metalloproteinases (MMP)
cleavage [20]. Our previous articles reported that the expression
of circulating or regional sB7-H3 was significantly elevated in
tumor or inflamed patients and was considered as a promising
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diseases [21–23]. Costimulatory molecules could be generated
from proteolytic cleavage, such as ICOS and PD-L1 [24],
and/or generated from mRNA splicing as PD-1 and CTLA-4
[25–26].However, whether the sB7-H3 could be resulted from
alternative mRNA splicing or whether both two isforms could
produce sB7-H3 remains unknown.
In this paper, we performed a phylogenetic study of B7-H3 gene
and determined the expression patterns of two known isoforms in
various species. Analyzing the sequences of 4IgB7-H3, we defined
a new conserved region, which is critical in determining whether
soluble form of B7-H3 will be generated. Moreover, structure
modeling study and fusion-binding assay suggested that 2IgB7-H3
and 4IgB7-H3 had divergent functions through binding to distinct
receptors on immune cells. Our in vitro experiment provided the
evidence that two isoforms had different functions: h2IgB7-H3
and mB7-H3 act as a positive costimulatory signal for T cells and
monocytes, whereas h4IgB7-H3 serves as an inhibitory costimu-
lator to T cells.
Results
Phylogenetic study of 4IgB7-H3 gene
In this study, B7-H3 sequences from 38 vertebrates from teleost
to tetrapod species were readily retrieved using TBLASTN and
the B7-H3 forms were deduced from analyzing the sequence data.
It suggested that besides human, 4IgB7-H3 isoform also existed in
guinea pig, cow, pig, dog, African elephant, panda, megabat,
Rhesus macaque, and Chimpanzee sequence. Genes’ location,
exon numbers and protein length of these 4IgB7-H3 molecules are
shown in Table 1. Thirty species with complete B7-H3 sequences
were used to generate phylogenetic trees and the species happened
duplication were underlined (Fig. 1A). In this tree, we observed
that short form B7-H3 with two domains in extro-celluar region
exists in pisces, ammphibia and aves which were labeled with VC
after the name, while some mammalian animals have long isoform
with four Ig-like domains. Although some mammalian species, as
mouse and rat, have short form B7-H3 due to exons losing, two
other domains’ encoding sequences were found in the introns.
Other mammalian animals with short form might have 4IgB7-H3
form or above-mentioned intron sequences as a result of
insufficient sequences presented in public databases.
We performed RT-PCR to amplify B7-H3 from the represen-
tative species (Fig. 1B). Two unambiguous bands were detected in
the guinea pig, dog, cow and macaque, with one predominant
band around 1200 bp, representing the predicted size of the
4IgB7-H3 and a minor band of 500 bp corresponded to the
predicted size of 2IgB7-H3. All bands were sequenced and
confirmed to be B7-H3 genes. We performed sequences analysis
between 4IgB7-H3 and 2IgB7-H3 and found that two forms of
B7-H3 transcripts were produced by alternative splicing from the
B7-H3 gene (Fig. 1C).
Sequence analysis of this new 4IgB7-H3 isoform
Human B7-H3 locus on chromosome 16 consisted of four
Ig-like domains: V1,C 1,V 2, and C2.V 1C1 share 96% sequence
homology with V2C2. Based on its genomic sequence data, B7-H3
underwent exon duplication leading to tandem repeated VC
domains (4IgB7-H3). We also observed the same event in other
species. Here, we analyzed 4IgB7-H3 DNA sequences in the dog,
cow, elephant, panda and guinea pig. The comparison between
two pairs of VC exons and introns were shown in Figure 2A. Ling
et al. had analyzed the interspecies alignment in human [3], and
we got similar results in human and other primate animals (data
not shown). Moreover, we found a conserved region (PQRSPT or
PHRSPT) in the C terminus of the first IgC domain (Fig. 2B),
which was absence in 2IgB7-H3. It might be produced by splicing
donor site in the exon duplication event.
Soluble B7-H3 shedding from 2IgB7-H3
As previously described, we developed an ELISA kit for the
measurement of sB7-H3 [21], which could be used for sB7-H3
measurement in serum and tumor cell culture supernatants. We
observed that sB7-H3 was released from 2IgB7-H3-transfected
L929 cell line, but not in 4IgB7-H3-transfected cell line. As shown
in Fig. 3A, an average level of sB7-H3 in L929/h2IgB7-H3
supernatants was 10.18 ng/ml, while no difference was detected
between L929/h4IgB7-H3 and L929/mock supernatants. West-
ern blot analysis was performed to determine the molecular weight
Table 1. Properties of 4IgB7-H3 in some vertebrates.
Species name genome positions
Protein length and
exon numbers reference
Guinea pigs (Cavia porcellus) GeneScaffold_6773: 25,646–34,702 521/7 ENSCPOT00000007869
Cow (Bos taurus) Chr.10: 19,539,333–19,552,113 556/9 ENSBTAT00000026300
Dog (Canis familiaris) Chr.30:39,973,976–39,987,154 538/9 GI:487638
African elephant (Loxodonta africana) GeneScaffold_1416: 5,710–17,518 527/10 ENSLAFT00000014929
Rhesuls macaque (Macaca mulatta) Chr.3: 27,037,697–27,032,447 534/9 ENSMMUT00000007668
Chimpanzee (Pan troglodytes) Chr.15:71,496,674–71,510,990 534/9 ENSPTRT00000013400
Human (Homo sapiens) Chr. 15: 73,976,554–74,006,859 534/9 ENST00000318443
marmoset (Callithrix jacchus) Chr. 10: 15,898,866–16,036,078 531/10 ENSCJAT00000060454
Gorila (Gorilla gorilla) Chr. 15: 53,382,251–53,415,302 534/10 ENSGGOT00000013982
Orangutan(Pongo pygmaeus) Chr. 15: 71,102,366–71,116,123 534/9 ENSPPYT00000007820
Pig (Sus scrofa) Chr. 7: 65,153,991–65,183,019 535/10 ENSSSCT00000002146
Panda(Ailuropoda melanoleuca) Scaffold_GL192695.1:9,955–20,517 531/8 ENSAMEG00000005720
Megabat(Pteropus vampyrus) GeneScaffold_718:10943–24975:1 529/9 ENSPVAP00000014464
The accession number with first letter ‘‘E’’ are Ensembl ID from Ensembl database and GI is from GenBank database.
doi:10.1371/journal.pone.0024751.t001
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H3- and mouse B7-H3-transfected cell supernatants (Fig. 3B and
Fig. 3C), as well as in lung cancer, uterine cervix cancer and colon
cancercellline supernatants(datanotshown).Inourpreviouspaper
[20], we reported the size of soluble B7-H3 form was around
16.5 kDa using biotinylated mAb 21D4 (prepared by our lab). In
this studies, we revised the size as approx. 37kDa using various
antibodies purchased from companies or prepared by our lab.
Our previous reports have verified that sB7-H3 could be released
from cell membrane protein by MMP digestion. Judged from the
size of the cleavage product of sB7-H3, the cleavage site should be
close to the trans-membrane region. Both B7-H3 isoforms had
the same sequence in this region, but the soluble form could only
be cleaved from 2IgB7-H3. Compared with 2IgB7-H3, 4IgB7-H3
has two pairs of V, C domains and the sequence similarity between
pairs exceeds 98% [3] except a region (PQRSPT or PHRSPT) in
the C terminus of the first IgC (Fig. 2B). So we presumed that the
new region might lead to B7-H3 remodeling, which block the
cleavage effect of MMP enzyme. To verify the effect of conserved
PQPSPT sequence, PQPSPT-deleted 4IgB7-H3 (4IgB7-H3-Del)
and PQRSPT-added 2IgB7-H3 (2IgB7-H3-Add) plasmids were
constructed and transfected to L929 cell line. Soluble B7-H3 was
identified in the 4IgB7-H3-Del culture supernatants by ELISA and
Western blot, while it was absent in 2IgB7-H3-Add culture
supernatants (Fig. 3). In addition, more sB7-H3 was detected from
4IgB7-H3-Del compared to 2IgB7-H3.
Figure 1. Identification and analysis of B7-H3 isoforms in different species. (A)phylogenetic analysis of the B7-H3 gene in vertebrates. The
tree was constructed from CLUSTAL generated amino acid alignments using the neighbor-joining method. Tree topography was evaluated by
bootstrapping 500 times with percentages shown at nodes. The species with duplication event were underlined and the species with only 2IgB7-H3
were labeling with VC after the name. (B) PCR analysis of different RNA samples using B7-H3-specific primer. A product of about 1200 bp corresponds
to a 4IgB7-H3 molecule, whereas a 500 bp would represent the 2IgB7-H3 gene. (C) Sequence alignment of deduced translated cow, guinea pig,
macaque and dog B7-H3 products. Dark bars or dotted lines above sequence alignment denote exon domains demarcated by genomic sequences.
doi:10.1371/journal.pone.0024751.g001
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Exon duplication and alternative splicing of B7-H3 locus
resulted in two similar splicing products, 4IgB7-H3 and 2IgB7-
H3, which shares over 95% sequence homology. Some researchers
have postulated that these two similar B7-H3 isoforms bind to
distinct receptors with opposing functions. The 3D structures of
these two proteins may shed light on the possible binding
receptors. Through PSI-Blast, we acquired PD-L1 x-ray structure
(3biSA)[27], which was close to B7-H3 amino acid sequence (34%
identity) and applied to our modeling (Fig. 4). We observed that
4IgB7-H3 has different numbers of helices and beta, and different
conformation compared with the 2IgB7-H3 isoform, and the
tandem duplicated domain V1C1 and V2C2 did not show similar
3D structure. In the 4IgB7-H3 model we could find the above
mentioned PQRSPT sequence was located in one loop region,
which might have an important role in remaining the structure.
Two putative receptors for B7-H3 on the surface of
activated T cells
Although a definite counter-receptor for B7-H3 has not been
clarified, most published reports suggested that B7-H3 binds to a
putative receptor expressed on PHA- or anti-CD3 mAb-activated
T cells [2,3]. To assess whether two isoforms of B7-H3 binds to
different receptors on activated T cells, cells were pre-incubated
with non-biotinylated proteins, and biotinylated h2IgB7-H3Ig/
h4IgB7-H3Ig were applied to examine a putative B7-H3 receptor.
We found both biotinylated proteins bound to isolated CD3
+ cells
from PHA-activated PBMC (Fig. 5A and Fig. 5B). Pre-incubation
with the same protein without biotin-labeling significantly
inhibited the binding (Fig. 5C and Fig. 5D), while incubation
with another excess non-biotinylated protein had no effect on the
binding (Fig. 5E and Fig. 5F). Taken together, these results
suggested two receptors might exist in activated T cells.
The effect of B7-H3 on T cells activation
L929/h2IgB7-H3 and CHO/mB7-H3 treatment significantly
enhanced the proliferation of T cells activated by anti-CD3 and
anti-CD28 Ab (Fig. 6A), and increased both mRNA and protein
expression of IL-2 and IFN-c (Fig. 6B and Fig. 6C). In contrast,
4IgB7-H3 treated T cells had decreased proliferative responses
(Fig. 6). Anti-B7-H3 Ab (prepared by our lab) at 1 mg/ml could
partially rescue the B7-H3 costimulatory or inhibitory effect on
proliferation (data not shown).
The effect of h2IgB7-H3 and mB7-H3 on LPS-activated
monocytes
Previous, we reported that sB7-H3 was elevated in patients
with bacterial infections and its level was correlated with plasma
TNF-a, which suggested that B7-H3 might be involved in
inflammatory reaction [18]. Interestingly, we detected a putative
receptor for B7-H3 on monocytes and peritoneal macrophages
from septic patients in the previous study. Here, we stimulated
Figure 2. Sequences analysis of 4IgB7-H3. (A) Interspecies alignment histograms of VC duplications of guinea pig, cow, dog, elephant, and
panda animals’ loci. Sizes of exon domains and percentage sequence identities are as indicated. (B) Multiple sequence alignments of the first (C1) and
second (C2) IgC domains from the vertebrates having 4IgB7-H3 isoform. The accession numbers are shown in Table 1.The c-like domains’ position are
acquired form ensemble databases. The amino acids in red line are special and redundancy in the first C domain. (C) The location of the special region
in 4IgB7-H3.
doi:10.1371/journal.pone.0024751.g002
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4IgB7-H3-Ig-fusion protein or various numbers of 2IgB7-H3,
4IgB7-H3/L929 cells in the presence of LPS. We also stimulated
murine monocytes from spleen with mB7-H3 protein or mB7-H3/
CHO cell. Human 2IgB7-H3 and murine B7-H3, significantly
augmented the mRNA expression and the release of LPS-
stimulated TNF-a, IL-6 (p,0.05) in a dose-dependent manner
(Fig. 7), while human 4IgB7-H3 had no effect.
Discussion
The evolution of immunological genetics and functions is critical
to understand current immunological biology in human and related
mammals. Here we examined the evolution of a costimulatory
molecule B7-H3, which is a new member of the B7 family, and has
two isoforms in humans while only one isoform in mice [3,17–18].
Through interrogatingvarious genomicdatabases,we observed that
B7-H3 genes in pisces, ammphibia and aves had a short form with
singleV andCdomains(Fig 1A), whilethe longform 4IgB7-H3with
pairs of VC domains was presented in many mammals for example
guinea pigs, dogs, cows, pigs, elephants, pandas, megabats and
higher primates(Table 1, Fig 1B). Further genomic data analysis in
these species revealed that the B7-H3 locus underwent exon
duplication leading to the emergence of 4IgB7-H3 with tandem
repeated VC domains (Fig 2A). In evolution, the segment of B7-H3
gene including two exons coding VC domain and an intron
happened cross over and then recombination occurred. Judged
from the B7-H3 phylogenetic tree and genomic sequence data we
presumed this DNA segment duplication event might happen from
the time prior to the emergence of mammalian animals,300
million years ago[29]. This time couldn’t be evident before all
mammalian species’ B7-H3 sequencing was completed. Although
duplication event also happened in some mammalian animals i.e.,
mouse and rat, they had only the single VC form due to exon losing
andthesequence encoding theotherputative C1 and V2 exonswere
presented in the intron region. Based on the comparison between
V1C2 and its duplication product C1V2, we found some nonsynon-
ymous mutation (data not shown) and a new region in the C1
domain, which suggested that the tandemly duplicated exons were
not redundant and might have new biology functions It was
important to discuss about the B7-H3 exon losing happened in
rodent lineage and we proposed that it might be caused by the
absence of the corresponding receptor of 4IgB7-H3 in these
animals, which could be further investigated after the B7-H3
potential receptor is identified. The expression of 4IgB7-H3 in
several mammalian animals was confirmed by RT-PCR. We
revealed that 2IgB7-H3 transcript could be produced by alternative
splicing of B7-H3 gene in these animals and the predominant
transcript was 4IgB7-H3, which was consistent with studies in
human [3,17–18,30]. These results indicated exon duplication in
B7-H3 evolution created a new isoform and this study is designed to
investigate the function of the new isoform.
Analyzed the 4IgB7-H3 sequences, there is a conserved region
in the C terminus of first IgC domain of various vertebrates’
4IgB7-H3, i.e., PQRSPT or PHRSPT, which was present in
Figure 3. Soluble B7-H3 was released from h2IgB7-H3, h4IgB7-H3-Del and mB7-H3, not from h4IgB7-H3 and h2IgB7-H3-Add genes.
(A) ELISA detecting of the culture supernatant of transfected cell lines (B) sB7-H3 of human releasing in transfected cells supernatant was detected by
western blot analysis (C) mouse sB7-H3 was determined in transfected supernatant cells by western blot analysis.
doi:10.1371/journal.pone.0024751.g003
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presenting form and functions of 4IgB7-H3, which is observed in
the following data. Our previous work determined that sB7-H3
was released from membrane protein mediated by MMP
digestion; and in the present study, we determined that the
molecular weight of sB7-H3 is around 37KD by Western blotting,
which was much close to the size of 2IgB7-H3 protein. Since there
was no soluble form in the 4IgB7-H3-transfected supernatant, we
proposed that 2IgB7-H3 was the only form to produce sB7-H3.
Furthermore, we generated a 4Ig-like DNA construct without this
conserved region or a 2Ig-like DNA construct with this region.
Interestingly, sB7-H3 could not be cleaved from membrane
protein if PQRSPT amino acids were added and soluble form
could only be produced when these amino acids were removed.
These results indicated that the present of this region might
interfere in the MMP cleavage. Judged from the size of sB7-H3,
we presumed the cleavage site should be close to the 2IgB7-H3
trans-membrane region. As two isoforms of B7-H3 had the same
sequences in the region adjacent to transmembrane region, we
speculated that PQRSPT motif might change the protein structure
to protect the site from MMP cleavage. In addition, proline was
often very flexible and having special role in the structure of
protein, which might give a support to the B7-H3 deformation
[31]. When this region was removed from 4IgB7-H3, two MMP
cleave sites was exposed, so we could found greater amount of
soluble form. The soluble form cleaved from 2IgB7-H3 and
4IgB7-H3-Del had the similar molecule weight.
B7-H3 was originally found be able to enhance T cell prolif-
eration, cytotoxicity and IFN-cproduction [2,4]. However, other
studies indicated that B7-H3 inhibited the activation of T cells and
cytokine production [9,11]. Moreover, a recent study showed that
the effects of B7-H3 on T cells depended on the activation state of
the T cells and B7-H3 had different effect on TCR-activated
T cells, resting T cells and cytokine-activated T cells [28]. Studies
with different results might suggest that two isoforms of B7-H3
have evolved divergent functions in immune responses through
binding to different receptors. So we examined the costimulatory
activity of human and mouse B7-H3 in vitro. Interestingly, we
found that h2IgB7-H3 and mB7-H3 enhanced T cell proliferation
and increased IFN-c and IL-2 releasing, while h4IgB7-H3 down-
regulated the activation of T cells (Fig. 7). Differential 3D structure
models of two isoforms and fusion-protein binding assays on
activated T cells also support the notion of the potential presence
of two receptors for B7-H3 with opposing functions. To our
knowledge, this is the first report providing both experimental and
bioinformatic evidence to support the existence of two receptors
for B7-H3 ligand.
Our previous study showed that significantly elevated levels of
sB7-H3 in the circulation were observed in patients diagnosed with
sepsis or bacterial meningitis [22]. Furthermore, levels of sB7-H3
in septic patients were correlated with their clinical outcomes and
circulating proinflammatory cytokines TNF-a and IL-6. In
addition, a putative receptor for B7-H3 was detected on
monocytes and peritoneal macrophages from septic patients.
These reports indicated that costimulatory molecule B7-H3 might
play an important role in infection immune. In this study we
demonstrated that h2IgB7-H3 and mB7-H3 are able to in-
crease the TNF-aand IL-6 production medicated LPS signaling.
Figure 4. Three-dimensional (3D) Structural models for B7-H3 proteins were proposed by homology modeling using the crystal
structure of known PD-L1. (A) the model of 2IgB7-H3 (B) the model of 4IgB7-H3.
doi:10.1371/journal.pone.0024751.g004
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results argue that the functions of 2IgB7-H3 protecting against
harmful infection require the ubiquitous existence of 2IgB7-H3 in
lower vertebrates to primate animals.
In summary, we performed in this work, for the first time,
a systemic analysis of the 2IgB7-H3 and 4IgB7-H3 expression in
various vertebrates and found duplication event happened in most
lineages of vertebrates. 2IgB7-H3 existing in all species could take
part in the infection immune in membrane-bound or soluble form
and upregulate the function of T cells and monocytes. In contrast,
4IgB7-H3 could only inhibit T cell response through binding
a different receptor, which needs to be verified through further
experiments after the receptors were found.
Materials and Methods
The Ethics Statement
Prior to commencing these experiments in this study, the
approval from the Ethics Review Board of Soochow University
was granted and the written informed consent was obtained from
each blood donor. In addition, the animal experiments in this
study were carried out in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health and the protocol was approved
by the Ethics Review Board of Soochow University. (Ethics permit
number of this study is 200895). All surgery in animal experiments
was performed under sodium pentobarbital anesthesia, and all
efforts were made to minimize suffering.
Identification and sequence analysis of B7-H3
B7-H3 or B7H3 or CD276 were used as queries to be searched
in several genome databases including GenBank (http://blast.
ncbi.nlm.nih.gov/Blast.cgi) ENSEMBL databases (http://www.
ensembl.org/index.html) and the Institute for Genomic Research
(http://compbio.dfci.harvard.edu/tgi/tgipage.html). ESTs repre-
senting partial sequences were used to search EST indices using
BLASTn and overlapping sequences were assembled using the
Assembler function of MacVector. Individual genomes were
interrogated using TBLASTN at ENSEMBL (www.ensembl.org/
index.html) or BLAT (http://genome.ucsc.edu/cgi-bin/hgBlat).
Phylogenetic trees were generated using MEGA4 software
(www.megasoftware.net; Kumar et al., Arizona State University,
Tempe, AZ, USA). The exon and intron sequences of selected
vertebrates were aligned using Align-X ClustalW module of
Vector NTI version 7.1 (Informax Inc., North Bethesda, MD,
USA). Multiple amino acid sequence alignments were performed
using ClustalW.
Figure 5. Surface expression of a putative receptor for B7-H3 on human activated T cells. Human PBMC from healthy donors (n=5) were
incubated with PHA (30 mg/ml) for up to 24 h. Data shown are one representative of five independent experiments. (A)(B) Cells were stained with
biotinylated h2IgB7-H3Ig or h4IgB7-H3Ig (1 mg) (red filled) or biotinylated human IgG (1 mg) as the control (grey), followed by dual-staining with PE-
conjugated streptavidin and FITC-conjugated anti-CD3 mAb. (C)(D) Data are presented with 10 mg non-biotinylated 2/4IgB7-H3-Ig followed by 1 mg
biotinylated 2/4IgB7-H3-Ig (grey dash line) or biotinylated 2/4IgB7-H3-Ig (red filled) or biotinylated human IgG (100 ng) staining as the control (grey).
(E)(F) Data are presented with 10 mg non-biotinylated 4/2IgB7-H3-Ig followed by 1 mg biotinylated 2/4IgB7-H3-Ig (grey dash line) or biotinylated 2/
4IgB7-H3-Ig (red filled) or biotinylated human IgG (100 ng) staining as the control (grey).
doi:10.1371/journal.pone.0024751.g005
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The modeling of the 3D structure of these two proteins was
performed by three automated homology modeling programs,
Geno 3D, Swissmodel and Modeller [32]. Briefly, PSI-BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) used for template struc-
ture search. 3D structure of PD-1/PD-L1 complex also named
3bisA was selected as template sequence. The template was
submitted to Geno3D and Swissmodel for automated homology
modeling. For Modeller, the template and target sequences were
carefully aligned to remove potential alignment errors. The overall
stereochemical quality of the protein was assessed by Ramchan-
dran plot analysis. The validation for structure models obtained
from the three software tools was performed by PROCHECK.
The structures were visualized using Swiss PdBviewer v 4.0.1.
Detection of B7-H3 isoforms in the guinea pig, dog, cow
and macaque by quantitative reverse transcription PCR
RNAs were extracted from the spleen of guinea pig, dog and
cow using TRIzol reagent (Takara, Japan). And cDNAs were
converted by an Oligo(dT) primer using primescript First cDNA
synthesis kit. The template used for macaque’s B7-H3 amplifica-
tion was extracted from Phytohaemagglutinin (PHA 30 mg/ml) -
activated peripheral blood mononuclear cell (PBMC). PCR
primers were designed to amplify the conserved parts of the B7-
H3 sequence. PCR products were subcloned into the PMDT-9
(Invitrogen, USA) vector and sequenced. Specific primers designed
upon the sequence of various species were used to characterize the
predominant product of B7-H3 in the guinea pig, dog,macaque
and cow.
Construction of 4IgB7-H3-Del and 2IgB7-H3-Add
plasmids
Based upon the alignments of 4IgB7-H3 protein sequences, we
found a conserved region in the C terminus of first IgC domain.
Two pairs of primers were designed with the 39 one phosphor-
ylated in the first pair primer and 59 one phosphorylated in the
second pair primer to amplify the two fragments of 4IgB7-H3.
Then PCR products were purified and ligated with T4 ligase
enzyme (Takara, Japan) and named 4IgB7-H3-Del. 2IgB7-H3
gene was added with a redundant sequence encoding PQRSPT
through overlap PCR and named 2IgB7-H3-Add. After been
sequenced, DNAs were subcloning into pRIES2 vector to make
pRIES2/4IgB7-H3-Del and pRIES2/2IgB7-H3-Add construct.
The new plasmids were transfected into the murine fibrosarcoma
cell line L929 with Lipofectamine 2000 (Invitrogen) and the stable
cell lines were acquired.
Cell culture, Antibody and Ig-fusion proteins
L929/h2IgB7-H3/ [33], L929/h4IgB7-H3 [30] and CHO/
mB7-H3 (unpublished paper) transfected cell lines were estab-
lished previously by our colleagues. Cells were cultured in 10%
fetal calf serum (FCS)(Gibco, USA)/RPMI-1640 in a 5% CO2,
37uC incubator. Meanwhile, the murine fibrosarcoma cell line
L929, Chinese hamster ovary cell line CHO (purchased from
American Tissue Culture Collection) and mock transfected cells
were also cultured as controls. When these cells were incubated for
a phase of growth, the supernatants were collected and frozen
at 280uC.
The goat-anti-human B7-H3 antibody and goat-anti-mouse
B7-H3 antibody were purchased from R&D systems. The human
2IgB7-H3-Ig-fusion protein and 4IgB7-H3-Ig-fusion protein were
constructed and prepared by our lab.
Analysis of two putative receptors in activated T cells
The PBMC were isolated by Ficoll-Hypaque through gradient
centrifugation from peripheral blood of healthy donors (n=5,
Suzhou Central Blood Bank, Suzhou, China) and were activated
using PHA (30 mg/ml) for 24 h. Cells were stained with
biotinylated h2IgB7-H3Ig (1 mg/ml) or biotinylated h4IgB7-
H3Ig (1 mg/ml). The other groups were stained with biotinylated
h2IgB7-H3Ig (1 mg/ml) after incubated with non-biotinylated
h2IgB7-H3 (10 mg/ml) or h4IgB7-H3 (10 mg/ml). There were
another groups stained with biotinylated h4IgB7-H3Ig (1 mg/ml)
after incubated with non-biotinylated h4IgB7-H3 (10 mg/ml) or
h2IgB7-H3 (10 mg/ml). Biotinylated human IgG (1 mg/ml) was
used as the control. All groups were followed by dual-staining with
PE-conjugated streptavidin and FITC-conjugated anti-CD3 mAb.
Cells were resuspended in PBS and analyzed by FACScan and
CellQuest software (Becton Dickinson, San Jose, CA). Prior to
commencing this study, the approval from the Ethics Review
Board of Soochow University was granted and the written
informed consent was obtained from each blood donors.
Soluble B7-H3 (sB7-H3) and cytokine measurement
The supernatants of L929, L929/mock, L929/h2IgB7-H3/,
L929/h4IgB7-H3, L929/4IgB7-H3-Del and L929/2IgB7-H3-
Add cells were collected and analyzed by sB7-H3 ELISA kit
(generated by our laboratory) [21]. Concentrations of human and
murine TNF-a, IL-6,IL-2 and IFN-c in the supernatants of LPS-
stimulated monocyte and activated T cells were assessed using
ELISA kit (R&D systems, USA).
Western blotting
The supernatantsof L929, L929/mock, L929/h2IgB7-H3/, L929/
h4IgB7-H3, L929/4IgB7-H3-Del,L929/2IgB7-H3-Add,CHO/mock
and CHO/mB7-H3 cells were collected and centrifuged at 12,0006g
for 15 min at 4uC.These supernatants were separated by SDS-PAGE,
and electrotransferred onto Immobilon-P membrane (Millipore).
Membrane was treated with 1 mg/ml goat anti-mouse or goat anti-
human B7-H3 Ab (R&D Systems, USA), then membranes were
washed three times with wash buffer before development with rabbit
anti-goat-HRP conjugate (Molecular Probes) at 0.2 mg/ml for 1 h at
4uC. Membranes were developed by chemiluminescence ECL
(Amersham Biosciences).
Isolation and treatment of human and mouse T cells
The PBMC were isolated by the same method as described
above. Human T cells were isolated from PBMC using a human
T Cell Enrichment Kit (Stem cell, Canada). The purity was more
than 98%, identified by anti-CD3 staining. L929/mock, L929/
h2IgB7-H3/ and L929/h4IgB7-H3were treated with mitomycin
(1 mg/ml, Sigma, USA) for 30 min, and washed three times with
PBS. T cells (10
5 cells/well) were cultured in flat-bottom 96-well
Figure 6. Costimulation of T cell response by h2IgB7-H3 and mB7-H3 while inhibition of T-cell activation by h4IgB7-H3. (A) Human T
cells and mouse T cells were co-cultured with L929 transfectants or CHO transfectants (ratio 10 1) stimulated with plate-bound anti-CD3 mAb and
soluble anti-CD28 for 72h. T cell counting was analyzed by cck-8. The data are representative for six independent experiments (B), (C) Culture
supernatant was harvested after 72h and subjected to IL-2, IFN-c measurement.(D) Expression of the IL-2 and IFN-c mRNA level in human and mouse
T cells with different transfected cells. b-acin was used as the control.
doi:10.1371/journal.pone.0024751.g006
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4 cells/well) and soluble anti-
CD28 antibody (5 mg/ml, prepared by our Lab). The 96-well
plates were coated with anti-CD3 antibody (0.5 mg/ml, Immuno-
tech Co., France) at 4uC overnight. Proliferation was determined
using Cell Counting Kit-8 (Dojindo Japan) for the last 5 hours of
a 72-h incubation period. Supernatants were harvested at 72 h
and assayed by multiplex ELISA screening (R&D systems, USA)
to measure cytokine production.
Mouse spleen was dissected and put into an ice-cold Hanks
balanced salt solution to generate a single cell suspension. Mouse
T cells were isolated using EasySepH Mouse T Cell Enrichment
Kit (Stem cell, Canada). The purity was more then 90%, identified
by anti-CD3 staining. Then Mock/CHO and mB7-H3/CHO
were treated as described in human T cells.
To determine the mRNA levels of cytolines, total RNA of
human and mouse T cells treated with L929/mock, L929/
h2IgB7-H3/, L929/h4IgB7-H3, CHO/mock and CHO/mB7-
H3 were extracted and subjected to RT-PCR. Reverse transcrip-
tion Reaction products were amplified with the primer pairs for
IL-2 and INF-c. As the keeping gene, PCR was also performed
with b-actin primers.
Isolation and treatment of human and mouse monocytes
CD14 positive selection kit (Stem cell, Canada) was used to
isolate human monocytes from PBMC and the purity of the
monocyte was more than 95% as identified by anti-CD14 staining.
After treated with 100 ng/ml LPS (Sigma), cell suspensions were
added to flat-bottom 96-well plates at a density of 10
5 cells/well,
and plates were incubated with L929 transfectants or B7-H3-Ig-
fusion protein at 37uC and 5% CO2 for 18 h. Supernatants were
harvested and frozen at 280uC until assayed.
CD11b
+ cells were separated from splenocyte suspensions using
a mouse CD11b positive selection kit (Stem cell, Canada). The
purity of the prepared monocytes was above 95% as identified by
anti-CD11b staining. Cells were stimulated with LPS (100 ng/ml)
and with CHO/mB7-H3 cells or mouse B7-H3-Ig-fusion protein
for 18 h. Supernatants were harvested and frozen at 280uC until
assayed. In addition the monocytes were collected to extract total
RNA.
Statistical analysis
All data are expressed as mean6SD. Statistical analysis was
performed with the Student’s t test and ANOVA. Correlations
were evaluated by the Pearson Correlation test. Values with
p,0.05 were considered statistically significant.
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